Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Collet

Showing results (211-220 of 408) with videos related to

Pageof 41
Sort By:
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 21, 2015
Triple antithrombotic therapy in atrial fibrillation patients with acute coronary syndromes or undergoing percutaneous coronary intervention or transcatheter aortic valve replacementDavide Capodanno, Gregory Y H Lip, Stephan Windecker, et al.
Circulation. Cardiovascular Interventions|November 11, 2015
Efficacy of ex vivo autologous and in vivo platelet transfusion in the reversal of P2Y12 inhibition by clopidogrel, prasugrel, and ticagrelor: the APTITUDE studyStephen A O'Connor, Julien Amour, Anne Mercadier, et al.
European Heart Journal|November 1, 2017
Questions and answers on diagnosis and management of patients with Peripheral Arterial Diseases: a companion document of the 2017 ESC Guidelines for the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Endorsed by: the European Stroke Organisation (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS)Victor Aboyans, Martin Björck, Marianne Brodmann, et al.
Open Heart|June 3, 2016
Switching between thienopyridines in patients with acute myocardial infarction and quality of careFrancois Schiele, Etienne Puymirat, Laurent Bonello, et al.
European Heart Journal|June 4, 2005
Non-ST-segment elevation acute coronary syndrome in patients with renal dysfunction: benefit of low-molecular-weight heparin alone or with glycoprotein IIb/IIIa inhibitors on outcomes. The Global Registry of Acute Coronary EventsJean-Philippe Collet, Gilles Montalescot, Giancarlo Agnelli, et al.
Archives of Cardiovascular Diseases|May 5, 2015
Sex-related differences after contemporary primary percutaneous coronary intervention for ST-segment elevation myocardial infarctionOlivier Barthélémy, Philippe Degrell, Emmanuel Berman, et al.
International Journal of Cardiology|November 15, 2011
Comparison of bleeding complications and one-year survival of low molecular weight heparin versus unfractioned heparin for acute myocardial infarction in elderly patients. The FAST-MI registryEtienne Puymirat, Nadia Aïssaoui, Jean-Philippe Collet, et al.
Archives of Cardiovascular Diseases|July 27, 2010
Impact of polyvascular disease on baseline characteristics, management and mortality in acute myocardial infarction. The Alliance projectAnouk Meizels, David Messika Zeitoun, Vincent Bataille, et al.
Archives of Cardiovascular Diseases|February 7, 2018
Management of antiplatelet therapy in patients undergoing elective invasive procedures: Proposals from the French Working Group on perioperative hemostasis (GIHP) and the French Study Group on thrombosis and hemostasis (GFHT). In collaboration with the French Society for Anesthesia and Intensive Care (SFAR)Anne Godier, Pierre Fontana, Serge Motte, et al.
Circulation|March 16, 2011
Platelet protease nexin-1, a serpin that strongly influences fibrinolysis and thrombolysisYacine Boulaftali, Benoit Ho-Tin-Noe, Ana Pena, et al.
Pageof 41

Showing results (211-220 of 408) with videos related to

Sort By:
Pageof 41
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 21, 2015
Triple antithrombotic therapy in atrial fibrillation patients with acute coronary syndromes or undergoing percutaneous coronary intervention or transcatheter aortic valve replacementDavide Capodanno, Gregory Y H Lip, Stephan Windecker, et al.
Circulation. Cardiovascular Interventions|November 11, 2015
Efficacy of ex vivo autologous and in vivo platelet transfusion in the reversal of P2Y12 inhibition by clopidogrel, prasugrel, and ticagrelor: the APTITUDE studyStephen A O'Connor, Julien Amour, Anne Mercadier, et al.
European Heart Journal|November 1, 2017
Questions and answers on diagnosis and management of patients with Peripheral Arterial Diseases: a companion document of the 2017 ESC Guidelines for the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Endorsed by: the European Stroke Organisation (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS)Victor Aboyans, Martin Björck, Marianne Brodmann, et al.
Open Heart|June 3, 2016
Switching between thienopyridines in patients with acute myocardial infarction and quality of careFrancois Schiele, Etienne Puymirat, Laurent Bonello, et al.
European Heart Journal|June 4, 2005
Non-ST-segment elevation acute coronary syndrome in patients with renal dysfunction: benefit of low-molecular-weight heparin alone or with glycoprotein IIb/IIIa inhibitors on outcomes. The Global Registry of Acute Coronary EventsJean-Philippe Collet, Gilles Montalescot, Giancarlo Agnelli, et al.
Archives of Cardiovascular Diseases|May 5, 2015
Sex-related differences after contemporary primary percutaneous coronary intervention for ST-segment elevation myocardial infarctionOlivier Barthélémy, Philippe Degrell, Emmanuel Berman, et al.
International Journal of Cardiology|November 15, 2011
Comparison of bleeding complications and one-year survival of low molecular weight heparin versus unfractioned heparin for acute myocardial infarction in elderly patients. The FAST-MI registryEtienne Puymirat, Nadia Aïssaoui, Jean-Philippe Collet, et al.
Archives of Cardiovascular Diseases|July 27, 2010
Impact of polyvascular disease on baseline characteristics, management and mortality in acute myocardial infarction. The Alliance projectAnouk Meizels, David Messika Zeitoun, Vincent Bataille, et al.
Archives of Cardiovascular Diseases|February 7, 2018
Management of antiplatelet therapy in patients undergoing elective invasive procedures: Proposals from the French Working Group on perioperative hemostasis (GIHP) and the French Study Group on thrombosis and hemostasis (GFHT). In collaboration with the French Society for Anesthesia and Intensive Care (SFAR)Anne Godier, Pierre Fontana, Serge Motte, et al.
Circulation|March 16, 2011
Platelet protease nexin-1, a serpin that strongly influences fibrinolysis and thrombolysisYacine Boulaftali, Benoit Ho-Tin-Noe, Ana Pena, et al.
Pageof 41